| scholarly article | Q13442814 |
| P2093 | author name string | William P Schiemann | |
| Jenny G Parvani | |||
| Chevaun D Morrison | |||
| P2860 | cites work | NF-kappaB activation, dependent on acetylation/deacetylation, contributes to HIF-1 activity and migration of bone metastatic breast carcinoma cells. | Q39813889 |
| TGFbeta-stimulated Smad1/5 phosphorylation requires the ALK5 L45 loop and mediates the pro-migratory TGFbeta switch | Q39903519 | ||
| Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells | Q39939949 | ||
| Lysyl oxidase-like 2 as a new poor prognosis marker of squamous cell carcinomas | Q39971722 | ||
| Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer | Q40079491 | ||
| Hypoxia/reoxygenation: a dynamic regulator of lysyl oxidase-facilitated breast cancer migration | Q40096756 | ||
| Human epithelial basal cells are cells of origin of prostate cancer, independent of CD133 status. | Q42506512 | ||
| Epithelial-mesenchymal transition induced by growth suppressor p12CDK2-AP1 promotes tumor cell local invasion but suppresses distant colony growth | Q43225336 | ||
| A phase II trial of imatinib mesylate monotherapy in patients with metastatic breast cancer. | Q43487632 | ||
| Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38MAPK and epithelial plasticity | Q45405811 | ||
| Imaging transforming growth factor-beta signaling dynamics and therapeutic response in breast cancer bone metastasis. | Q52594636 | ||
| Differential regulation of the two RhoA-specific GEF isoforms Net1/Net1A by TGF-β and miR-24: role in epithelial-to-mesenchymal transition. | Q52617207 | ||
| E-cadherin is a ligand for integrin α2β1 | Q58057935 | ||
| High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1 | Q79643431 | ||
| Src phosphorylates Tyr284 in TGF-beta type II receptor and regulates TGF-beta stimulation of p38 MAPK during breast cancer cell proliferation and invasion | Q80171744 | ||
| To differentiate or not--routes towards metastasis | Q84106913 | ||
| Cancer stem cells | Q84976114 | ||
| Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling | Q24298472 | ||
| The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner | Q24308947 | ||
| A molecular role for lysyl oxidase-like 2 enzyme in snail regulation and tumor progression | Q24314451 | ||
| ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing | Q24321530 | ||
| Epithelial-mesenchymal transition-derived cells exhibit multilineage differentiation potential similar to mesenchymal stem cells | Q24599620 | ||
| Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche | Q24606366 | ||
| miR-21 and miR-31 Converge on TIAM1 to Regulate Migration and Invasion of Colon Carcinoma Cells | Q24613084 | ||
| Matrix crosslinking forces tumor progression by enhancing integrin signaling | Q24646370 | ||
| MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA | Q24648090 | ||
| The epithelial-mesenchymal transition generates cells with properties of stem cells | Q24650786 | ||
| The basics of epithelial-mesenchymal transition | Q24652992 | ||
| The miR-200 and miR-221/222 microRNA families: opposing effects on epithelial identity | Q27010233 | ||
| An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype | Q27339197 | ||
| Epithelial-mesenchymal transitions in development and disease | Q27860630 | ||
| Tensional homeostasis and the malignant phenotype | Q27860932 | ||
| The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 | Q27861068 | ||
| Alternative isoform regulation in human tissue transcriptomes | Q27861118 | ||
| Tumour invasion and metastasis initiated by microRNA-10b in breast cancer | Q28131829 | ||
| miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis | Q28236600 | ||
| RETRACTED: Lysyl oxidase is essential for hypoxia-induced metastasis | Q28236828 | ||
| Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility | Q28261746 | ||
| TGFbeta in Cancer | Q28288866 | ||
| Molecular definition of breast tumor heterogeneity | Q28292256 | ||
| TGF-β regulates isoform switching of FGF receptors and epithelial-mesenchymal transition | Q28512991 | ||
| Type II Transforming Growth Factor-β Receptor Recycling Is Dependent upon the Clathrin Adaptor Protein Dab2 | Q28588905 | ||
| Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics | Q28751743 | ||
| SMAD proteins control DROSHA-mediated microRNA maturation | Q28941771 | ||
| Integrins in cancer: biological implications and therapeutic opportunities | Q29614536 | ||
| Reversibility of epithelial-mesenchymal transition (EMT) induced in breast cancer cells by activation of urokinase receptor-dependent cell signaling | Q37371663 | ||
| X-linked inhibitor of apoptosis protein and its E3 ligase activity promote transforming growth factor-{beta}-mediated nuclear factor-{kappa}B activation during breast cancer progression | Q37372003 | ||
| beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium | Q37460431 | ||
| Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis | Q37467183 | ||
| MicroRNAs: novel regulators in the hallmarks of human cancer | Q37493501 | ||
| Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer. | Q37721840 | ||
| Endoplasmic reticulum protein 29 (ERp29): An emerging role in cancer | Q37797638 | ||
| Cancer cells in epithelial-to-mesenchymal transition and tumor-propagating-cancer stem cells: distinct, overlapping or same populations | Q37885165 | ||
| Mechanism of the mesenchymal-epithelial transition and its relationship with metastatic tumor formation | Q37917310 | ||
| MicroRNAs: critical regulators of epithelial to mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in cancer progression | Q37970478 | ||
| Induction of epithelial-mesenchymal transition by transforming growth factor β. | Q38006771 | ||
| TGF-β-induced epithelial-mesenchymal transition: a link between cancer and inflammation | Q38012975 | ||
| Regulation of EMT by TGFβ in cancer. | Q38019712 | ||
| Endoplasmic reticulum protein 29 regulates epithelial cell integrity during the mesenchymal-epithelial transition in breast cancer cells | Q39356840 | ||
| Suppression of the epithelial-mesenchymal transition by Grainyhead-like-2. | Q39387840 | ||
| TGF-β drives epithelial-mesenchymal transition through δEF1-mediated downregulation of ESRP. | Q39451094 | ||
| The BMP2/7 heterodimer inhibits the human breast cancer stem cell subpopulation and bone metastases formation | Q39458532 | ||
| Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer. | Q39460209 | ||
| TRAF6 ubiquitinates TGFβ type I receptor to promote its cleavage and nuclear translocation in cancer. | Q39532727 | ||
| Altered TGF-β signaling in a subpopulation of human stromal cells promotes prostatic carcinogenesis. | Q39595827 | ||
| Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors | Q39646992 | ||
| An ESRP-regulated splicing programme is abrogated during the epithelial-mesenchymal transition | Q39667327 | ||
| Exon-based clustering of murine breast tumor transcriptomes reveals alternative exons whose expression is associated with metastasis | Q39747555 | ||
| An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors | Q29615393 | ||
| TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia | Q29618875 | ||
| Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer | Q29619481 | ||
| Generation of breast cancer stem cells through epithelial-mesenchymal transition | Q29619717 | ||
| Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features | Q29620020 | ||
| uPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells | Q30443804 | ||
| Down-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer. | Q30502431 | ||
| TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study | Q33293871 | ||
| p130Cas is required for mammary tumor growth and transforming growth factor-beta-mediated metastasis through regulation of Smad2/3 activity. | Q33553472 | ||
| Activated Abl kinase inhibits oncogenic transforming growth factor-beta signaling and tumorigenesis in mammary tumors | Q33613286 | ||
| ALK5 phosphorylation of the endoglin cytoplasmic domain regulates Smad1/5/8 signaling and endothelial cell migration | Q33705264 | ||
| PGE2 receptor EP2 mediates the antagonistic effect of COX-2 on TGF-beta signaling during mammary tumorigenesis | Q33752909 | ||
| Mechanisms of disease: epithelial-mesenchymal transition--does cellular plasticity fuel neoplastic progression? | Q33755906 | ||
| Role of integrins in cancer: survey of expression patterns | Q33774941 | ||
| Mechanisms of the epithelial-mesenchymal transition by TGF-beta | Q33804105 | ||
| Roles for the type III TGF-beta receptor in human cancer | Q33872593 | ||
| miR-10b targets Tiam1: implications for Rac activation and carcinoma migration | Q33966873 | ||
| Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha | Q34065396 | ||
| Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes | Q34100400 | ||
| The organization of tight junctions in epithelia: implications for mammary gland biology and breast tumorigenesis | Q34103481 | ||
| A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts | Q34125363 | ||
| Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation | Q34174349 | ||
| Lysyl oxidase-like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomas | Q34197948 | ||
| Non-Smad TGF-beta signals | Q34443708 | ||
| Integrin beta1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs | Q34608570 | ||
| Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenation | Q34613520 | ||
| Homeoprotein Six1 Increases TGF-β Type I Receptor and Converts TGF-β Signaling from Suppressive to Supportive for Tumor Growth | Q34768886 | ||
| Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networks | Q34781947 | ||
| p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. | Q34787898 | ||
| Transforming growth factor-β and the hallmarks of cancer | Q34789300 | ||
| Lysyl oxidase contributes to mechanotransduction-mediated regulation of transforming growth factor-β signaling in breast cancer cells | Q34887552 | ||
| The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis | Q34933986 | ||
| An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition | Q34977307 | ||
| TGFbeta/TNF(alpha)-mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype | Q35085542 | ||
| Hypoxia-induced Jagged2 promotes breast cancer metastasis and self-renewal of cancer stem-like cells | Q35134466 | ||
| Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization | Q35204515 | ||
| Epithelial-Mesenchymal Transition in tumor microenvironment | Q35230386 | ||
| Eya2 is required to mediate the pro-metastatic functions of Six1 via the induction of TGF-β signaling, epithelial-mesenchymal transition, and cancer stem cell properties | Q35243673 | ||
| Beta3 integrin and Src facilitate transforming growth factor-beta mediated induction of epithelial-mesenchymal transition in mammary epithelial cells | Q35605733 | ||
| Disruption of bone morphogenetic protein receptor 2 (BMPR2) in mammary tumors promotes metastases through cell autonomous and paracrine mediators. | Q35778924 | ||
| Matrix rigidity regulates a switch between TGF-β1-induced apoptosis and epithelial-mesenchymal transition | Q35790882 | ||
| The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer. | Q35928749 | ||
| Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells | Q36006612 | ||
| Metastatic growth from dormant cells induced by a col-I-enriched fibrotic environment | Q36215812 | ||
| A phase II study of imatinib mesylate and capecitabine in metastatic breast cancer: Southwest Oncology Group Study 0338 | Q36435548 | ||
| Differential cadherin expression: potential markers for epithelial to mesenchymal transformation during tumor progression | Q36847939 | ||
| Mesenchymal to epithelial transition in development and disease. | Q36857740 | ||
| Transforming growth factor-beta and microRNA:mRNA regulatory networks in epithelial plasticity | Q36857841 | ||
| Treatment for chronic myelogenous leukemia: the long road to imatinib | Q36900105 | ||
| Applying the discovery of the Philadelphia chromosome | Q36900109 | ||
| Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton. | Q36922699 | ||
| Cox-2 inactivates Smad signaling and enhances EMT stimulated by TGF-beta through a PGE2-dependent mechanisms | Q36959011 | ||
| The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells | Q37040558 | ||
| TGF-β stimulates Pyk2 expression as part of an epithelial-mesenchymal transition program required for metastatic outgrowth of breast cancer | Q37040574 | ||
| Grb2 binding to Tyr284 in TbetaR-II is essential for mammary tumor growth and metastasis stimulated by TGF-beta | Q37041510 | ||
| Altered TAB1:I kappaB kinase interaction promotes transforming growth factor beta-mediated nuclear factor-kappaB activation during breast cancer progression | Q37041538 | ||
| Noncanonical TGF-β signaling during mammary tumorigenesis | Q37044600 | ||
| Role of TGF-β and the tumor microenvironment during mammary tumorigenesis | Q37044604 | ||
| Deconstructing the mechanisms and consequences of TGF-β-induced EMT during cancer progression | Q37044614 | ||
| TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta | Q37052635 | ||
| Three-dimensional context regulation of metastasis | Q37111021 | ||
| Cancer-associated transforming growth factor beta type II receptor gene mutant causes activation of bone morphogenic protein-Smads and invasive phenotype | Q37155797 | ||
| The TGF-beta paradox in human cancer: an update | Q37261631 | ||
| Role of TGF-beta in the tumor stroma | Q37264582 | ||
| MicroRNAs as regulators of epithelial-mesenchymal transition. | Q37300965 | ||
| Imatinib mesylate (Gleevec) in advanced breast cancer-expressing C-Kit or PDGFR-beta: clinical activity and biological correlations | Q37326191 | ||
| The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-beta signaling | Q37328463 | ||
| Roles of TGF-beta family signaling in stem cell renewal and differentiation | Q37359959 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 30-40 | |
| P577 | publication date | 2013-03-05 | |
| P1433 | published in | Cancer Letters | Q326372 |
| P1476 | title | The relevance of the TGF-β Paradox to EMT-MET programs | |
| P478 | volume | 341 |
| Q38693858 | A kinetic model of multiple phenotypic states for breast cancer cells. |
| Q37295389 | Activation of anaphase-promoting complex by p53 induces a state of dormancy in cancer cells against chemotherapeutic stress |
| Q92129438 | Are Integrins Still Practicable Targets for Anti-Cancer Therapy? |
| Q49385083 | Ascending the PEAK1 toward targeting TGFβ during cancer progression: Recent advances and future perspectives |
| Q52662320 | CXCL5 regulation of proliferation and migration in human non-small cell lung cancer cells. |
| Q33678275 | Chronic inflammation and cytokines in the tumor microenvironment |
| Q26991721 | Combining radiation and immunotherapy: a new systemic therapy for solid tumors? |
| Q55260487 | Confirmation of a metastasis-specific microRNA signature in primary colon cancer. |
| Q38772722 | Crosstalk between TGF-β signaling and miRNAs in breast cancer metastasis |
| Q93161614 | CtBP promotes metastasis of breast cancer through repressing cholesterol and activating TGF-β signaling |
| Q64976524 | Cytokines and radiation-induced pulmonary injuries. |
| Q26753299 | Cytokines in cancer drug resistance: Cues to new therapeutic strategies |
| Q42432955 | Cytoplasmic PML promotes TGF-β-associated epithelial-mesenchymal transition and invasion in prostate cancer |
| Q35214539 | Deptor enhances triple-negative breast cancer metastasis and chemoresistance through coupling to survivin expression |
| Q90751050 | Effect of Stromal Cells in Tumor Microenvironment on Metastasis Initiation |
| Q90311523 | Epigenetic Regulation of Inflammatory Cytokine-Induced Epithelial-To-Mesenchymal Cell Transition and Cancer Stem Cell Generation |
| Q89719708 | Epithelial to Mesenchymal Transition: A Mechanism that Fuels Cancer Radio/Chemoresistance |
| Q38939465 | Epithelial-mesenchymal transition confers resistance to selective FGFR inhibitors in SNU-16 gastric cancer cells |
| Q64080378 | Estrogen-related receptor alpha induces epithelial-mesenchymal transition through cancer-stromal interactions in endometrial cancer |
| Q39482832 | Estrogen-related receptor α participates transforming growth factor-β (TGF-β) induced epithelial-mesenchymal transition of osteosarcoma cells |
| Q35237503 | Extracellular molecules involved in cancer cell invasion |
| Q30241069 | From obesity to cancer: a review on proposed mechanisms |
| Q47112052 | Functions of pancreatic stellate cell-derived soluble factors in the microenvironment of pancreatic ductal carcinoma |
| Q38601572 | ITGA1 is a pre-malignant biomarker that promotes therapy resistance and metastatic potential in pancreatic cancer |
| Q52680995 | Identification and validation a TGF-β-associated long non-coding RNA of head and neck squamous cell carcinoma by bioinformatics method. |
| Q94543868 | Interleukin-6 compared to the other Th17/Treg related cytokines in inflammatory bowel disease and colorectal cancer |
| Q38901553 | Intratumoral polymorphonuclear granulocyte is associated with poor prognosis in squamous esophageal cancer by promoting epithelial-mesenchymal transition |
| Q35130596 | Isolation and characterization of mammalian cells expressing the Arf promoter during eye development |
| Q36413193 | KLF8 promotes tumorigenesis, invasion and metastasis of colorectal cancer cells by transcriptional activation of FHL2. |
| Q38904950 | Loss of GDF10/BMP3b as a prognostic marker collaborates with TGFBR3 to enhance chemotherapy resistance and epithelial-mesenchymal transition in oral squamous cell carcinoma |
| Q86022545 | Lung metastasis of pancreatic carcinoma is regulated by TGFβ signaling |
| Q38241992 | Lysyl oxidase in cancer research |
| Q36018529 | MRI detection of breast cancer micrometastases with a fibronectin-targeting contrast agent. |
| Q39505481 | MiR-497 enhances metastasis of oral squamous cell carcinoma through SMAD7 suppression |
| Q38810246 | MicroRNA-663 suppresses cell invasion and migration by targeting transforming growth factor beta 1 in papillary thyroid carcinoma |
| Q58801546 | Microglia/Astrocytes-Glioblastoma Crosstalk: Crucial Molecular Mechanisms and Microenvironmental Factors |
| Q64962892 | Multi-experiment nonlinear mixed effect modeling of single-cell translation kinetics after transfection. |
| Q38214771 | Mysteries of TGF-β Paradox in Benign and Malignant Cells |
| Q60949488 | NK Cell-Based Glioblastoma Immunotherapy |
| Q51730965 | Novel microtubule inhibitor MPT0B098 inhibits hypoxia-induced epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma. |
| Q33902576 | Oncostatin M promotes cancer cell plasticity through cooperative STAT3-SMAD3 signaling |
| Q35235907 | P21 activated kinase-1 mediates transforming growth factor β1-induced prostate cancer cell epithelial to mesenchymal transition |
| Q38709672 | P300 promotes migration, invasion and epithelial-mesenchymal transition in a nasopharyngeal carcinoma cell line |
| Q37195998 | Partial epithelial-mesenchymal transition in keloid scars: regulation of keloid keratinocyte gene expression by transforming growth factor-β1 |
| Q38293612 | Pivotal role of pervasive neoplastic and stromal cells reprogramming in circulating tumor cells dissemination and metastatic colonization. |
| Q37071218 | Recent discoveries concerning the involvement of transcription factors from the Grainyhead-like family in cancer |
| Q41472817 | Ring finger protein 125, as a potential highly aggressive and unfavorable prognostic biomarker, promotes the invasion and metastasis of human gallbladder cancers via activating the TGF- β1-SMAD3-ID1 signaling pathway |
| Q39438840 | Roles of Grainyhead-like transcription factors in cancer |
| Q39108925 | SUMO and the robustness of cancer |
| Q39113994 | Silencing the roadblocks to effective triple-negative breast cancer treatments by siRNA nanoparticles |
| Q89953555 | Sulfatase 1: a new Jekyll and Hyde in hepatocellular carcinoma? |
| Q89091522 | TGF-β Stimulation of EMT Programs Elicits Non-genomic ER-α Activity and Anti-estrogen Resistance in Breast Cancer Cells |
| Q33632419 | TGF-β triggers rapid fibrillogenesis via a novel TβRII-dependent fibronectin-trafficking mechanism |
| Q28075605 | TGFΒ-induced transcription in cancer |
| Q92564621 | TGFβ1-Smad canonical and -Erk noncanonical pathways participate in interleukin-17-induced epithelial-mesenchymal transition in Sjögren's syndrome |
| Q90746289 | TNFAIP8 promotes the migration of clear cell renal cell carcinoma by regulating the EMT |
| Q90403133 | The calcium channel proteins ORAI3 and STIM1 mediate TGF-β induced Snai1 expression |
| Q28070337 | The crosstalk between lncRNA and microRNA in cancer metastasis: orchestrating the epithelial-mesenchymal plasticity |
| Q38633203 | The epithelial-mesenchymal transition in cancer: a potential critical topic for translational proteomic research. |
| Q52730181 | The post-translational modification, SUMOylation, and cancer (Review). |
| Q42342102 | The propensity for epithelial-mesenchymal transitions is dictated by chromatin states in the cancer cell of origin |
| Q38788923 | The role of TGF-β and its crosstalk with RAC1/RAC1b signaling in breast and pancreas carcinoma |
| Q64085590 | The role of miRNAs in the invasion and metastasis of cervical cancer |
| Q55514789 | The role of sentrin-specific protease 2 substrate recognition in TGF-β-induced tumorigenesis. |
| Q90318651 | Traditional Chinese Medicine and regulatory roles on epithelial-mesenchymal transitions |
| Q59798921 | Transfection of T-Box Transcription Factor and Synergistically Promote Self-Renewal and Invasive Phenotype in Oral Cancer Cells |
| Q48182968 | Transforming Growth Factor β/NR4A1-Inducible Breast Cancer Cell Migration and Epithelial-to-Mesenchymal Transition Is p38α (Mitogen-Activated Protein Kinase 14) Dependent |
| Q55177521 | Transforming Growth Factor-β Signaling Plays a Pivotal Role in the Interplay Between Osteosarcoma Cells and Their Microenvironment. |
| Q58754397 | Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis |
| Q33661529 | Two faces of TGF-beta1 in breast cancer |
| Q38767898 | Up-regulation of miR-455-5p by the TGF-β-SMAD signalling axis promotes the proliferation of oral squamous cancer cells by targeting UBE2B. |
| Q37337989 | Valproic acid inhibits irradiation-induced epithelial-mesenchymal transition and stem cell-like characteristics in esophageal squamous cell carcinoma |
| Q34448186 | Vicious cycle of TGF-β signaling in tumor progression and metastasis |
| Q33678879 | Yiqi Huayu Jiedu Decoction Inhibits the Invasion and Metastasis of Gastric Cancer Cells through TGF-β/Smad Pathway. |
| Q41552126 | ZEB1 confers stem cell-like properties in breast cancer by targeting neurogenin-3. |
Search more.